(RY) Royal Bank of Canada - Overview
Exchange: NYSE •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA7800871021
Stock:
Total Rating 53
Risk 40
Buy Signal -0.69
| Risk 5d forecast | |
|---|---|
| Volatility | 17.3% |
| Relative Tail Risk | -1.41% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.07 |
| Alpha | 38.98 |
| Character TTM | |
|---|---|
| Beta | 0.450 |
| Beta Downside | 0.341 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.56% |
| CAGR/Max DD | 1.15 |
EPS (Earnings per Share)
Revenue
Description: RY Royal Bank of Canada
Royal Bank of Canada operates as a diversified financial service company worldwide. Its Personal Banking segment offers home equity financing, personal lending, chequing and savings accounts, private banking, auto financing, mutual funds, GICs, credit cards, and payment products and solutions. The company's Commercial Banking segments provides lending, deposit and transaction banking products and services. Its Wealth Management segment provides a suite of wealth, investment, trust, banking, credit, and other solutions to clients; asset management products to institutional and individual clients; and asset and investor services to financial institutions, asset managers, and asset owners. The company's Insurance segment offers life, health, travel, wealth, annuities, property and casualty, and reinsurance advice and solutions; digital platforms; and independent brokers and partners, as well as client-led advice and solutions. The company's Capital Markets segment offers advisory and origination, sales and trading, lending and financing, and transaction banking services to corporations, institutional clients, asset managers, private equity firms, and governments. The company was founded in 1864 and is based in Toronto, Canada.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 20.36b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 1.32 > 1.0 |
| NWC/Revenue: -981.4% < 20% (prev -940.6%; Δ -40.82% < -1%) |
| CFO/TA 0.02 > 3% & CFO 55.22b > Net Income 20.36b |
| Net Debt (747.57b) to EBITDA (28.73b): 26.02 < 3 |
| Current Ratio: 0.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.41b) vs 12m ago -0.46% < -2% |
| Gross Margin: 45.26% > 18% (prev 0.40%; Δ 4486 % > 0.5%) |
| Asset Turnover: 6.11% > 50% (prev 6.19%; Δ -0.08% > 0%) |
| Interest Coverage Ratio: 0.36 > 6 (EBITDA TTM 28.73b / Interest Expense TTM 70.83b) |
Altman Z'' -3.53
| A: -0.58 (Total Current Assets 206.49b - Total Current Liabilities 1554.49b) / Total Assets 2325.01b |
| B: 0.04 (Retained Earnings 96.94b / Total Assets 2325.01b) |
| C: 0.01 (EBIT TTM 25.65b / Avg Total Assets 2248.29b) |
| D: 0.05 (Book Value of Equity 117.80b / Total Liabilities 2185.86b) |
| Altman-Z'' Score: -3.53 = D |
Beneish M -2.94
| DSRI: 1.23 (Receivables 41.21b/32.89b, Revenue 137.36b/134.48b) |
| GMI: 0.89 (GM 45.26% / 40.34%) |
| AQI: 1.00 (AQ_t 0.91 / AQ_t-1 0.90) |
| SGI: 1.02 (Revenue 137.36b / 134.48b) |
| TATA: -0.01 (NI 20.36b - CFO 55.22b) / TA 2325.01b) |
| Beneish M-Score: -2.94 (Cap -4..+1) = A |
What is the price of RY shares?
As of February 24, 2026, the stock is trading at USD 170.59 with a total of 1,202,889 shares traded.
Over the past week, the price has changed by +0.70%, over one month by +1.21%, over three months by +14.74% and over the past year by +48.49%.
Over the past week, the price has changed by +0.70%, over one month by +1.21%, over three months by +14.74% and over the past year by +48.49%.
Is RY a buy, sell or hold?
Royal Bank of Canada has received a consensus analysts rating of 4.31.
Therefore, it is recommended to buy RY.
- StrongBuy: 8
- Buy: 5
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 174.5 | 2.3% |
| Analysts Target Price | 174.5 | 2.3% |
RY Fundamental Data Overview February 21, 2026
Market Cap CAD = 328.94b (239.82b USD * 1.3716 USD.CAD)
P/E Trailing = 16.5247
P/E Forward = 14.7493
P/S = 3.853
P/B = 2.5283
P/EG = 2.3749
Revenue TTM = 137.36b CAD
EBIT TTM = 25.65b CAD
EBITDA TTM = 28.73b CAD
Long Term Debt = 12.52b CAD (from longTermDebt, last quarter)
Short Term Debt = 476.56b CAD (from shortTermDebt, last quarter)
Debt = 834.96b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 747.57b CAD (from netDebt column, last quarter)
Enterprise Value = 998.62b CAD (328.94b + Debt 834.96b - CCE 165.28b)
Interest Coverage Ratio = 0.36 (Ebit TTM 25.65b / Interest Expense TTM 70.83b)
EV/FCF = 18.85x (Enterprise Value 998.62b / FCF TTM 52.98b)
FCF Yield = 5.31% (FCF TTM 52.98b / Enterprise Value 998.62b)
FCF Margin = 38.57% (FCF TTM 52.98b / Revenue TTM 137.36b)
Net Margin = 14.82% (Net Income TTM 20.36b / Revenue TTM 137.36b)
Gross Margin = 45.26% ((Revenue TTM 137.36b - Cost of Revenue TTM 75.19b) / Revenue TTM)
Gross Margin QoQ = 46.47% (prev 46.31%)
Tobins Q-Ratio = 0.43 (Enterprise Value 998.62b / Total Assets 2325.01b)
Interest Expense / Debt = 2.11% (Interest Expense 17.64b / Debt 834.96b)
Taxrate = 20.42% (1.39b / 6.83b)
NOPAT = 20.41b (EBIT 25.65b * (1 - 20.42%))
Current Ratio = 0.13 (Total Current Assets 206.49b / Total Current Liabilities 1554.49b)
Debt / Equity = 6.00 (Debt 834.96b / totalStockholderEquity, last quarter 139.09b)
Debt / EBITDA = 26.02 (Net Debt 747.57b / EBITDA 28.73b)
Debt / FCF = 14.11 (Net Debt 747.57b / FCF TTM 52.98b)
Total Stockholder Equity = 135.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.91% (Net Income 20.36b / Total Assets 2325.01b)
RoE = 15.08% (Net Income TTM 20.36b / Total Stockholder Equity 135.07b)
RoCE = 17.38% (EBIT 25.65b / Capital Employed (Equity 135.07b + L.T.Debt 12.52b))
RoIC = 3.20% (NOPAT 20.41b / Invested Capital 638.28b)
WACC = 3.35% (E(328.94b)/V(1163.90b) * Re(7.57%) + D(834.96b)/V(1163.90b) * Rd(2.11%) * (1-Tc(0.20)))
Discount Rate = 7.57% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.33%
[DCF Debug] Terminal Value 84.74% ; FCFF base≈40.13b ; Y1≈34.67b ; Y5≈27.39b
Fair Price DCF = 60.70 (EV 832.56b - Net Debt 747.57b = Equity 84.99b / Shares 1.40b; r=5.90% [WACC]; 5y FCF grow -16.58% → 2.90% )
EPS Correlation: 73.74 | EPS CAGR: 7.47% | SUE: 1.41 | # QB: 2
Revenue Correlation: 86.90 | Revenue CAGR: 24.88% | SUE: 2.79 | # QB: 1
EPS next Quarter (2026-04-30): EPS=3.78 | Chg30d=+0.038 | Revisions Net=+1 | Analysts=9
EPS current Year (2026-10-31): EPS=15.71 | Chg30d=+0.090 | Revisions Net=+2 | Growth EPS=+8.9% | Growth Revenue=+5.8%
EPS next Year (2027-10-31): EPS=17.39 | Chg30d=+0.170 | Revisions Net=+6 | Growth EPS=+10.7% | Growth Revenue=+4.9%
P/E Trailing = 16.5247
P/E Forward = 14.7493
P/S = 3.853
P/B = 2.5283
P/EG = 2.3749
Revenue TTM = 137.36b CAD
EBIT TTM = 25.65b CAD
EBITDA TTM = 28.73b CAD
Long Term Debt = 12.52b CAD (from longTermDebt, last quarter)
Short Term Debt = 476.56b CAD (from shortTermDebt, last quarter)
Debt = 834.96b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 747.57b CAD (from netDebt column, last quarter)
Enterprise Value = 998.62b CAD (328.94b + Debt 834.96b - CCE 165.28b)
Interest Coverage Ratio = 0.36 (Ebit TTM 25.65b / Interest Expense TTM 70.83b)
EV/FCF = 18.85x (Enterprise Value 998.62b / FCF TTM 52.98b)
FCF Yield = 5.31% (FCF TTM 52.98b / Enterprise Value 998.62b)
FCF Margin = 38.57% (FCF TTM 52.98b / Revenue TTM 137.36b)
Net Margin = 14.82% (Net Income TTM 20.36b / Revenue TTM 137.36b)
Gross Margin = 45.26% ((Revenue TTM 137.36b - Cost of Revenue TTM 75.19b) / Revenue TTM)
Gross Margin QoQ = 46.47% (prev 46.31%)
Tobins Q-Ratio = 0.43 (Enterprise Value 998.62b / Total Assets 2325.01b)
Interest Expense / Debt = 2.11% (Interest Expense 17.64b / Debt 834.96b)
Taxrate = 20.42% (1.39b / 6.83b)
NOPAT = 20.41b (EBIT 25.65b * (1 - 20.42%))
Current Ratio = 0.13 (Total Current Assets 206.49b / Total Current Liabilities 1554.49b)
Debt / Equity = 6.00 (Debt 834.96b / totalStockholderEquity, last quarter 139.09b)
Debt / EBITDA = 26.02 (Net Debt 747.57b / EBITDA 28.73b)
Debt / FCF = 14.11 (Net Debt 747.57b / FCF TTM 52.98b)
Total Stockholder Equity = 135.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.91% (Net Income 20.36b / Total Assets 2325.01b)
RoE = 15.08% (Net Income TTM 20.36b / Total Stockholder Equity 135.07b)
RoCE = 17.38% (EBIT 25.65b / Capital Employed (Equity 135.07b + L.T.Debt 12.52b))
RoIC = 3.20% (NOPAT 20.41b / Invested Capital 638.28b)
WACC = 3.35% (E(328.94b)/V(1163.90b) * Re(7.57%) + D(834.96b)/V(1163.90b) * Rd(2.11%) * (1-Tc(0.20)))
Discount Rate = 7.57% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.33%
[DCF Debug] Terminal Value 84.74% ; FCFF base≈40.13b ; Y1≈34.67b ; Y5≈27.39b
Fair Price DCF = 60.70 (EV 832.56b - Net Debt 747.57b = Equity 84.99b / Shares 1.40b; r=5.90% [WACC]; 5y FCF grow -16.58% → 2.90% )
EPS Correlation: 73.74 | EPS CAGR: 7.47% | SUE: 1.41 | # QB: 2
Revenue Correlation: 86.90 | Revenue CAGR: 24.88% | SUE: 2.79 | # QB: 1
EPS next Quarter (2026-04-30): EPS=3.78 | Chg30d=+0.038 | Revisions Net=+1 | Analysts=9
EPS current Year (2026-10-31): EPS=15.71 | Chg30d=+0.090 | Revisions Net=+2 | Growth EPS=+8.9% | Growth Revenue=+5.8%
EPS next Year (2027-10-31): EPS=17.39 | Chg30d=+0.170 | Revisions Net=+6 | Growth EPS=+10.7% | Growth Revenue=+4.9%